Table 6.

End points observed within subjects according to SBP target tier

Characteristics	First Tier, SBP 170–200 mm Hg, n = 18	Second Tier, SBP 140–170 mm Hg, n = 20	Third Tier, SBP 110–140 mm Hg, n = 22
Treatment failure	0	0	9 (41%)
N (%) with SAE within 72 hrs	0	1 (5%)	3 (14%)
N (%) with neurologic deterioration within 24 hrs	1 (6%)	2 (10%)	4 (18%)
N (%) with symptomatic hematoma expansion	0	1 (5%)	4 (18%)
N (%) with asymptomatic hematoma expansion	6 (33%)	2 (10%)	3 (14%)
N (%) with in-hospital mortality	2 (11%)	1 (5%)	1 (4 %)
N (%) with 3-mo mortality	3 (17%)	2 (10%)	5 (23%)
1-mo favorable outcome, mRS 0–2	4 (3 missing)	6 (3 missing)	4 (2 missing)
3-mo favorable outcome, mRS 0–2	8 (3 missing)	9 (4 missing)	7 (2 missing)

SBP, systolic blood pressue; SAE, serious adverse event; mRS, modified Rankin score.